Intensity Therapeutics Inc
INTS
Get informed when a big investor buys or sells
+ FollowMarket Cap$11.49M
Close$
$0.87
78.2% downside
Current Fair Value
78.2% downsideOvervalued by 78.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $11.49 Million |
|---|---|
| Enterprise Value | $2.05 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-8.56 |
| Beta | 3.03 |
| Outstanding Shares | 27,066,070 |
Return
| Return on Equity | -121.15% |
|---|---|
| Return on Assets | -96.89% |
| Return on Invested Capital | -123.79% |
Valuation & Multiples
| P/E Ratio | -0.88 |
|---|---|
| PEG | -4.75 |
| Price to Sales | -4.0 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | -78.96 |
| Enterprise Value to EBIT | -0.18 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.05 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 11, 2026
EPS Estimate
$-0.87
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$-0.94
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.71%▼ 0.44% |
|---|---|
| Total Invested | $1.06M▼ 33.08% |
| Investors Holding | 14▼ 21.00% |
ESG Score
No data